Rigidifying cancer cells for better immunotherapy
EPFL scientists have found that stiffening the membranes of cancer cells can lead to improved immunotherapy outcomes. Preclinical tests show that it can increase long-term survival rates to nearly 50%.
New program supports femtech entrepreneurs
Thirty startups have raised CHF 60 million in funding through Tech4Eva, continental Europe’s first program designed specifically for entrepreneurs in the field of femtech, or technology for women’s health. On 7 December, Switzerland’s first femtech conference will mark the end of Tech4Eva’s inaugural year – and kick off the next funding round.